Smoking Clinical Trials in St Louis, Missouri
4 studies are recruiting for smoking in St Louis, Missouri right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
This study evaluates the efficacy and safety of brenipatide when compared to placebo for reducing the risk of relapse to cigarette smoking in adults who have recently quit. Study participation will last approximately 34 weeks with up to 17 study visits, which includes a 2-week screening period, 24-…
- Stage
- Phase 2
- Ages
- 18 to 75
- Site
- Arch Clinical Trials, St Louis, Missouri
- Locations
- 29 in total
- Run by
- Eli Lilly and Company
-
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
This study examines the application of precision treatment intervention for smoking cessation from both the clinician perspective and patient perspective, and compares it to usual care on tobacco treatment in the primary care setting. The precision treatment intervention includes personalized tobac…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Washington University School of Medicine, St Louis, Missouri
- Run by
- Washington University School of Medicine
-
Precision Treatment to Promote Smoking Cessation and Survival in Oncology Patients
This study evaluates the feasibility and preliminary effects of precision tobacco treatment, compared to usual care, on promoting tobacco treatment in oncology patients and providers in the oncology care setting. The precision treatment intervention includes personalized tobacco treatment recommend…
- Stage
- Not phased
- Ages
- 18 to 89
- Site
- John Cochran Veteran's Affairs Medical Center, St Louis, Missouri
- Locations
- 2 in total
- Run by
- Washington University School of Medicine
-
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
The overall purpose of this study will be to assess primary combustible cigarette users' abstinence from smoking their usual brand of combustible cigarettes at the end of the study, when provided with an electronic nicotine delivery system (ENDS) power unit (2) and varying levels of access to tobac…
- Stage
- Not phased
- Ages
- 21 to 65
- Site
- Sago St. Louis, St Louis, Missouri
- Locations
- 7 in total
- Run by
- RAI Services Company
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.